Nu Skin Enterprises (FRA:NUS) EBITDA Margin %: 5.99% (As of Mar. 2026) — 56% Below Median


FRA:NUS Nu Skin Enterprises Inc FRA:NUS
63 GF Score
Price €4.51
GF Value €7.93
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nu Skin Enterprises EBITDA Margin %?

Nu Skin Enterprises FRA:NUS +4.21% 63 EBITDA Margin % is 5.99% as of Mar. 2026, which is 56% below its 10-year median of 13.60. GuruFocus rates FRA:NUS with a GF Score™ of 63/100 and a GF Value™ of €7.93 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Nu Skin Enterprises ranks worse than 50.03% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nu Skin Enterprises's EBITDA for the three months ended in Mar. 2026 was €17 Mil. Nu Skin Enterprises's Revenue for the three months ended in Mar. 2026 was €277 Mil. Therefore, Nu Skin Enterprises's EBITDA margin for the quarter that ended in Mar. 2026 was 5.99%.


Nu Skin Enterprises  (FRA:NUS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Nu Skin Enterprises EBITDA Margin % Related Terms


Nu Skin Enterprises EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Nu Skin Enterprises's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nu Skin Enterprises EBITDA Margin % Chart

Nu Skin Enterprises Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.44 7.86 6.25 -4.55 17.67

Nu Skin Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.73 11.13 8.85 9.48 5.99

FRA:NUS vs HNST, ACU, WALD: EBITDA Margin % Comparison

For the Household & Personal Products subindustry, Nu Skin Enterprises's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nu Skin Enterprises EBITDA Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nu Skin Enterprises's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Nu Skin Enterprises's EBITDA Margin % falls into.


FRA:NUS
63GF Score
Nu Skin Enterprises Inc FRA:NUS
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nu Skin Enterprises EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Nu Skin Enterprises's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=224.095/1268.326
=17.67 %

Nu Skin Enterprises's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=16.6/277.326
=5.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 5.99% mean?
Nu Skin Enterprises (FRA:NUS) has a EBITDA Margin % of 5.99% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nu Skin Enterprises and its competitors. This is 56% below median its historical median of 13.60. According to the industry distribution chart, Nu Skin Enterprises ranks #977 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 50%.
Is Nu Skin Enterprises' EBITDA Margin % too high?
Nu Skin Enterprises' current EBITDA Margin % of 5.99% is 56% below median its 10-year median of 13.60. The Consumer Packaged Goods industry median EBITDA Margin % is 8.99. Nu Skin Enterprises' value of 5.99% is 33.4% below this industry median. Based on the distribution chart, Nu Skin Enterprises ranks #977 out of 1953 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Nu Skin Enterprises has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nu Skin Enterprises' EBITDA Margin % compare to HNST and ACU?
According to the Consumer Packaged Goods industry distribution chart, Nu Skin Enterprises ranks #977 out of 1953 companies for EBITDA Margin %. This puts Nu Skin Enterprises in the upper half of its industry. The industry median EBITDA Margin % is 8.99. Nu Skin Enterprises' value of 5.99% is 33.4% below this benchmark. While the company's 10-year median is 13.60 vs. the industry median of 8.99, Nu Skin Enterprises has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nu Skin Enterprises's current EBITDA Margin % of 5.99% is 33.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nu Skin Enterprises and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nu Skin Enterprises's current EBITDA Margin % is 5.99%, which is 56% below median its own 10-year median of 13.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nu Skin Enterprises stock overvalued right now?
Based on GuruFocus' analysis, Nu Skin Enterprises (FRA:NUS) is currently considered Possible Value Trap. The stock's GF Value™ is €7.93, compared to a current price of €4.51 — trading 43.2% below its estimated fair value. The current EBITDA Margin % is 5.99%, which is 56% below median its 10-year median of 13.60 and 33.4% below the Consumer Packaged Goods industry median of 8.99. Nu Skin Enterprises' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nu Skin Enterprises (FRA:NUS), the current EBITDA Margin % is 5.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nu Skin Enterprises (FRA:NUS) Overvalued in 2026?

Based on GuruFocus' analysis, Nu Skin Enterprises stock appears to be undervalued. The current stock price of €4.51 is trading 43.2% below its estimated GF Value™ of €7.93. GuruFocus considers Nu Skin Enterprises to be Possible Value Trap.

Key valuation signals for FRA:NUS:

  • EBITDA Margin %: 5.99% (56% below median its 10-year median of 13.60)
  • GF Value™: €7.93 vs. price of €4.51 (43.2% below fair value)
  • GF Score™: 63/100 with 4 warning signs
  • Industry Position: 33.4% below the Consumer Packaged Goods median (#977 of 1953)

No single metric tells the full story. See the FRA:NUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nu Skin Enterprises Business Description

Other Exchanges NUS:USA
Address 75 West Center Street, Provo, UT, USA, 84601
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
63GF Score

Get the complete analysis for FRA:NUS

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.51
Price
€7.93
GF Value